Skip to content
REGN Regeneron Pharmaceuticals Inc NASDAQ
966.30 USD 0.29% +2.75
OPEN 971.04
PREV CLOSE 963.55
DAY RANGE 976.75 - 962.41
VOLUME 314.8K
AVG. VOLUME 463.6K
52 WEEK RANGE 998.33 - 684.81
Interactive Brokers Logotype

Buy REGN stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 106.1B
Enterprise value 95.7B
Trailing pe 27.783209
Forward pe 20.44214
Peg ratio 20.44214
Price to sales ttm 8.085797
Price to book mrq 3.9852023
Enterprise to revenue 7.296
Enterprise to ebitda 20.562

Financials

Fiscal year ends 2023-12-31
Most recent quarter 2023-12-31
Profit margin 0.30141002
Operating margin 0.29202
Return on assets ttm 0.08494
Return on equity ttm 0.16258
Income statement
Revenue ttm 13.1B
Revenue per share ttm 122.935
Quarterly revenue growth 0.006
Gross profit ttm 11.3B
Ebitda 5.1B
Net income to common ttm 4B
Diluted eps ttm 34.78
Quarterly earnings growth yoy -0.031
Balance sheet
Total cash mrq 10.8B
Total cash per share mrq 100.918
Total debt mrq 2.7B
Total debt to equity mrq 10.407
Current ratio mrq 5.69
Book value per share mrq 242.472
Cash flow
Operating cash flow ttm 4.6B
Levered free cash flow ttm 2.8B

Stock statistics

Shares outstanding 107.9M
Float shares 102.8M
Avg 10 volume 463.1K
Avg 90 volume 439.6K
Shares short 1.4M
Short ratio 2.65
Short percent of shares outstanding 0.0147
Percent held by insiders 0.02582
Percent held by institutions 0.89188004

Stock price summary

Fifty two week low 684.81
Fifty two week high 998.33
Fifty two week change 16.02
Beta 0.11
Day 50 ma 957.3264
Day 200 ma 844.101

Dividends and splits

Regeneron Pharmaceuticals (REGN) company profile

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products to treat severe medical conditions. Some of the firm’s products include EYLEA injection and ARCALYST injection. The company’s commercialized medicines are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and other rare diseases.